The Treatment Landscape of Metastatic Urothelial Carcinoma: Second-Line Systemic Therapy
Survival Analysis
Re-irradiation combined with bevacizumab for recurrent glioblastoma beyond bevacizumab failure: survival outcomes and prognostic factors | Scientific Reports
Let's Flip: An Approach to Understand Median Follow-up by the Reverse Kaplan-Meier Estimator from a Statistical Programmer's
Survival Analysis in R
Kaplan-Meier survival analysis
Overall survival for suPAR levels above or below a 12 ng/mL cutoff.... | Download Scientific Diagram
Survival Analysis in R
Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer | NEJM
Survival (time to event) data: median survival times | The BMJ
How Median Follow-up Time Informs Survival Outcomes: Lessons from a Trial of Acute Myeloid Patients Treated with Venetoclax and Azacitidine - ScienceDirect
Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study | British Journal of Cancer
primed.info
Survival curves. (A) Overall survival (median 18.2 months). (B) PS of... | Download Scientific Diagram
A retrospective analysis of changes in distant and breast cancer related disease-free survival events in adjuvant breast cancer trials over time | Scientific Reports
Kaplan-Meier plot of overall survival. Median follow-up was 21.3 months... | Download Scientific Diagram
Survival Analysis in R
Laying the Foundation Towards Long-Term Survival in Patients with High-Risk Acute Myeloid Leukaemia - European Medical Journal
Median overall survival (mOS) and median progression-free survival... | Download Scientific Diagram
Real-world time trends in overall survival, treatments and patient characteristics in HR+/HER2− metastatic breast cancer: an observational study of the SONABRE Registry - The Lancet Regional Health – Europe
Survival Analysis
a Kaplan?Meier relapse-free survival (median follow-up time 42 months)... | Download Scientific Diagram
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer | NEJM
Society of Urologic Oncology - MANAGEMENT AND OUTCOMES OF PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR UROTHELIAL CARCINOMA OF THE BLADDER: EVOLUTION OF THE UNIVERSITY OF SOUTHERN CALIFORNIA EXPERIENCE OVER 3,347 CASES
